News

Shedding weight may no longer be a prickly issue as Eli Lilly’s weight-loss pill moves closer to launch
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participants experienced an average weight loss of 7.2 kg with the 36 mg ...
Shedding weight without the jab: Eli Lilly’s weight-loss pill moves closer to launch
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the ...
Lilly’s oral diabetes pill shows potential for blood sugar control and weight loss in global trial
The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...
Verywell Health on MSN21h
Daily GLP-1 Pill Shows Promise for Diabetes and Weight Loss, Eli Lilly Says
A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...
What is the weight-loss drug Orfoglipron and could it replace Ozempic?
The drug is still going through trials, but the medical company Lilly, behind it, is hopeful it can be rolled out soon. In ...